Back to Search Start Over

CLINICAL AND ECONOMIC BENEFITS OF NATIONAL IMMUNIZATION WITH THE 13-VALENT COMPARED TO 7-AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINES IN GREECE